Bicycle Therapeutics plc Gain (Loss) on Extinguishment of Debt
Bicycle Therapeutics plc (BCYC) reported Gain (Loss) on Extinguishment of Debt of -$954.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-03-17
- Bicycle Therapeutics plc gain (loss) on extinguishment of debt for the quarter ending 2024-12-31 was $0.00.
- Bicycle Therapeutics plc gain (loss) on extinguishment of debt for the quarter ending 2024-09-30 was -$954.00K.
- Bicycle Therapeutics plc gain (loss) on extinguishment of debt for fiscal 2024 was -$954.00K.
| Period end | Gain (Loss) on Extinguishment of Debt | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$954.00K derived: sum of 2 quarters · filed 2026-03-17 | -$954.00K 10-K · filed 2026-03-17 | ||
| 2024-09-30 | -$954.00K 10-Q · filed 2025-10-30 | -$954.00K 10-Q · filed 2025-10-30 | |||
| 2024-07-09 | -$1.00M 10-Q · filed 2024-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |